Eli Lilly Subsidiary Gets $3.9M In Fees Under Octane Ruling
A Pennsylvania federal judge Wednesday approved a special master's recommendation of $3.9 million in fees to Eli Lilly and Co. subsidiary Avid Radiopharmaceuticals for its expenses defending a bad-faith patent suit...To view the full article, register now.
Already a subscriber? Click here to view full article